Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Heterozygous reelin mutations cause autosomal-dominant lateral temporal epilepsy.
Dazzo E, Fanciulli M, Serioli E, Minervini G, Pulitano P, Binelli S, Di Bonaventura C, Luisi C, Pasini E, Striano S, Striano P, Coppola G, Chiavegato A, Radovic S, Spadotto A, Uzzau S, La Neve A, Giallonardo AT, Mecarelli O, Tosatto SC, Ottman R, Michelucci R, Nobile C. Dazzo E, et al. Among authors: luisi c. Am J Hum Genet. 2015 Jun 4;96(6):992-1000. doi: 10.1016/j.ajhg.2015.04.020. Am J Hum Genet. 2015. PMID: 26046367 Free PMC article.
Epilepsy surgery below the age of 5 years: Are we still in time to preserve developmental and intellectual functions?
Cappelletti S, Correale C, Mercier M, Pavia GC, Falamesca C, De Benedictis A, Marras CE, Quintavalle C, Luisi C, Pepi C, Chiarello D, Vigevano F, De Palma L, Specchio N. Cappelletti S, et al. Among authors: luisi c. Epilepsia Open. 2024 Oct;9(5):1901-1909. doi: 10.1002/epi4.13027. Epub 2024 Sep 2. Epilepsia Open. 2024. PMID: 39223819 Free PMC article.
Myoclonic super-refractory status epilepticus with favourable evolution in a teenager with FIRES: Is the association of vagus nerve stimulation and cannabidiol effective?
Bonardi CM, Furlanis GM, Toldo I, Guarrera B, Luisi C, Pettenazzo A, Nosadini M, Boniver C, Sartori S, Landi A. Bonardi CM, et al. Among authors: luisi c. Brain Dev. 2023 May;45(5):293-299. doi: 10.1016/j.braindev.2023.01.004. Epub 2023 Jan 30. Brain Dev. 2023. PMID: 36725381 Free article.
The clinical phenotype of autosomal dominant lateral temporal lobe epilepsy related to reelin mutations.
Michelucci R, Pulitano P, Di Bonaventura C, Binelli S, Luisi C, Pasini E, Striano S, Striano P, Coppola G, La Neve A, Giallonardo AT, Mecarelli O, Serioli E, Dazzo E, Fanciulli M, Nobile C. Michelucci R, et al. Among authors: luisi c. Epilepsy Behav. 2017 Mar;68:103-107. doi: 10.1016/j.yebeh.2016.12.003. Epub 2017 Jan 28. Epilepsy Behav. 2017. PMID: 28142128 Free PMC article.
Juvenile myoclonic epilepsy: Long-term prognosis and risk factors.
Pietrafusa N, La Neve A, de Palma L, Boero G, Luisi C, Vigevano F, Specchio N. Pietrafusa N, et al. Among authors: luisi c. Brain Dev. 2021 Jun;43(6):688-697. doi: 10.1016/j.braindev.2021.02.005. Epub 2021 Mar 27. Brain Dev. 2021. PMID: 33781581 Review.
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST).
Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Chiesa V, Dainese F, De Maria G, Didato G, Falcicchio G, Fanella M, Ferlazzo E, Fisco G, Gangitano M, Giallonardo AT, Giorgi FS, La Neve A, Mecarelli O, Montalenti E, Piazza F, Pulitano P, Quarato PP, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership. Lattanzi S, et al. CNS Drugs. 2021 Dec;35(12):1289-1301. doi: 10.1007/s40263-021-00856-3. Epub 2021 Sep 2. CNS Drugs. 2021. PMID: 34476770 Free PMC article. Clinical Trial.
Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST).
Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Chiesa V, Dainese F, De Maria G, Didato G, Falcicchio G, Fanella M, Ferlazzo E, Fisco G, Gangitano M, Giallonardo AT, Giorgi FS, La Neve A, Mecarelli O, Montalenti E, Piazza F, Pulitano P, Quarato PP, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership. Lattanzi S, et al. CNS Drugs. 2021 Dec;35(12):1329-1331. doi: 10.1007/s40263-021-00868-z. CNS Drugs. 2021. PMID: 34787838 Free PMC article. No abstract available.
Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures.
Lattanzi S, Ascoli M, Canafoglia L, Paola Canevini M, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group. Lattanzi S, et al. Epilepsia. 2022 May;63(5):e42-e50. doi: 10.1111/epi.17223. Epub 2022 Mar 26. Epilepsia. 2022. PMID: 35278335 Free PMC article.
39 results